翰思艾泰-B（03378.HK）股東結構 - 機構持倉、大股東與內部人士｜長橋證券

© 2026 Longbridge｜服務條款隱私政策

股東類型

私人企業79.49%
公眾及其他12.05%
上市公司4.72%
機構投資者2.32%
個人與內幕人士1.43%

主要股東

主要股東最新
股東
Cai Zhang Biotechnology (Hangzhou) Co., Ltd	40.60%	5,530.00 萬	0.00%	+0	31/12/2025
Hanx Biopharmaceuticals (HK) Limited	13.06%	1,779.36 萬	0.00%	+0	31/12/2025
Hangzhou Hongye Ruiji Investment Partnership (Limited Partnership)	9.44%	1,286.05 萬	0.00%	+0	08/01/2026
Beijing Lapam Biopharmaceutical Venture Capital Center (Limited Partnership)	9.44%	1,286.05 萬	0.00%	+0	08/01/2026
Betta Pharmaceuticals Co., Ltd.	4.72%	643.02 萬	0.00%	+0	23/12/2025
Wuhan Donggaorensi Equity Investment Partnership (Limited Partnership)	2.51%	341.61 萬	0.00%	+0	23/12/2025
Wuhan Hanx Tai Management Consulting Partnership (L.P.)	2.24%	304.51 萬	0.00%	+0	31/12/2025
Hangzhou Tailong Venture Capital Partnership Enterprise (L.P.)	1.88%	256.21 萬	0.00%	+0	23/12/2025
Yangtze Investment (HK) Limited	1.32%	180.40 萬	0.00%	+0	23/12/2025
Qixiang LiCEO, CSO, GM & Executive Director	1.00%	136.64 萬	0.00%	+0	31/12/2025
Tibet Lapam Small and Medium Enterprise Development Fund Equity Investment Partnership (Limited Part	0.88%	119.56 萬	0.00%	+0	08/01/2026
Lapam Capital	0.44%	59.60 萬	0.00%	+0	08/01/2026
Min LiuCOO, Vice GM & Executive Director	0.40%	54.66 萬	0.00%	+0	31/12/2025
Liao Tong	0.02%	2.14 萬	0.00%	+0	23/12/2025
Jieyu XiaoCFO, Secretary of the Board & Executive Director	<0.01%	1.11 萬	0.00%	+0	31/12/2025
Zou Zhiyong	<0.01%	1,710.00	0.00%	+0	23/12/2025